Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by β-adrenergic stimulation in 3T3-L1 adipocytes

Journal of Endocrinology

Volumn 189, Issue 3, 2006, Pages 665-670

  Kralisch, S ^a   Lossner, U ^a   Bluher, M ^a   Paschke, R ^a   Stumvoll, M ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; ISOPRENALINE; MESSENGER RNA; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME RELEASE; ENZYME SYNTHESIS; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADRENERGIC BETA-AGONISTS; ANIMALS; BUCLADESINE; CELL LINE, TRANSFORMED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; INSULIN; ISOPROTERENOL; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UP-REGULATION;

EID: 33745228419     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06645     Document Type: Article

References (24)

1. Alexander CM, Selvarajan S, Mudgett J & Werb Z 2001 Stromelysin-1 regulates adipogenesis during mammary gland involution. Journal of Cell Biology 152 693-703.
2. Beaudeux JL, Giral P, Bruckert E, Foglietti MJ & Chapman MJ 2004 Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clinical and Chemical Laboratory Medicine 42 121-131.
3. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E & Tartare-Deckert S 2003 Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. Journal of Biological Chemistry 278 11888-11896.
4. Collins S & Surwit RS 2001 The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Progress in Hormone Research 56 309-328.
5. Crandall DL, Hausman GJ & Kral JG 1997 A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4 211-232.
6. Demeulemeester D, Collen D & Lijnen HR 2005 Effect of matrix. metalloproteinase inhibition on adipose tissue development. Biochemical and Biophysical Research Communications 329 105-110.
7. Facchini FS, Stoohs RA & Reaven GM 1996 Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. American Journal of Hypertension 9 1013-1017.
8. Fasshauer M, Klein J, Ueki K, Kriauciunas KM, Benito M, White MF & Kahn CR 2000 Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. Journal of Biological Chemistry 275 25494-25501.
9. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R 2001a Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Letters 507 142-146.
10. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R 2001b Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 ad pocytes. FEBS Letters 500 60-63.
11. Fasshauer M, Klein J, Lossner U & Paschke R 2003 Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Hormone and Metabolic Research 35 147-152.
12. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A & Stetler-Stevenson M 1998 In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. Journal of Clinical Investigation 102 2002-2010.
13. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E & Iwata K 1992 Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Letters 298 29-32.
14. Hoieggen A, Fossum E, Nesbitt SD, Palmieri V & Kjeldsen SE 2000 Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica. Blood Pressure 9 83-90.
15. Kahn BB & Flier JS 2000 Obesity and insulin resistance. Journal of Clinical Investigation 106 473-481.
16. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M & Fasshauer M 2005a Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. Journal of Endocrinology 185 R1-R8.
17. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M Fasshauer M 2005b Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. American Journal of Physiology. Endocrinology and Metabolism 289 E586-E590.
18. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M & Fasshauer M 2005c Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes. FEBS Letters 579 6417-6422.
19. Laborda J 1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Research 19 3998.
20. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L & Collen D 2002 Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 22 374-379.
21. Lijnen HR, Demeulemeester D, Van Hoef B, Collen D & Maquoi E 2003 Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thrombosis and Haemostasis 89 249-255.
22. Maison P, Byrne CD, Hales CN & Wareham NJ 2000 Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: a link between the sympathetic nervous and the metabolic syndrome? Metabolism 49 81-87.
23. Maquoi E, Munaut C, Colige A, Collen D & Lijnen HR 2002 Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 1093-1101.
24. Reaven GM, Lithell H & Landsberg L 1996 Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. New England Journal of Medicine 334 374-381.